Send an RFQ for Biolegend 927301, Avidin/Biotin Blocking System (Previously Covance catalog# SIG-31126). Iright supports global sourcing and international shipment for life science and laboratory products.
| Formulation | Blocking Kit. The Avidin and Biotin Solutions contain 0.09% sodium azide.Previous lots of this product may have been formulated with 0.1% or 0.05% NaN3 instead of 0.09% NaN3. For further information please contact BioLegend Technical Support or Customer Service. |
|---|---|
| Storage & Handling | Store between 2°C and 8°C. |
| Application | IHC, WB |
| Recommended Usage | The optimal working dilution should be determined for each specific assay condition. Blocking Procedure: For paraffin-embedded tissues: To be performed after the antigen retrieval and serum block but before primary antibody incubation. 1. Incubate the Avidin Solution for 10-15 minutes at room temperature. 2. Incubate with the Biotin Solution for 10-15 minutes at room temperature. |
| Application Notes | BioLegend's Avidin/Biotin Blocking System is intended for use in immunohistochemistry and immunoblotting procedures. The purpose is to decrease the signal caused by endogenous avidin, biotin, or biotin-binding proteins when immunostaining specimens with detection systems that rely on avidin-biotin or steptavidin-biotin chemistry. Nonspecific staining due to these factors commonly resembles a diffuse, weak, cytoplasmic pattern. |
Unless otherwise stated, the minimum order amount is USD 1,000.
For orders below USD 1,000, an additional handling fee may apply, or we may arrange local delivery / local handover where available.
All quotations are subject to final confirmation, including product availability, lead time, batch information, shipping cost, and applicable export or handling requirements.
For quotation requests, please send an RFQ from website or contact:
Please send inquiries directly to us in the “To” field. Emails sent via BCC, mass mailing, or with unrelated recipients may be automatically filtered and will not be processed.
| Product Citations |
|---|
| Bednarski E, et al. 2022. MBio. 13:e0084022. PubMed Cacialli P, et al. 2022. EMBO J. 41:e108536. PubMed Deisher A, et al. 2022. STAR Protoc. 3:101663. PubMed Feldt J, et al. 2020. Osteoarthr Cartil Open. 2:100124. PubMed Olde Hanhof CJA, et al. 2023. Front Cell Dev Biol. 11:1086823. PubMed Mooney JP, et al. 2022. Wellcome Open Res. 7:134. PubMed Klarquist J, et al. 2021. Cell Rep. 36:109591. PubMed Ferrian S, et al. 2021. Cell Rep Med. 2:100419. PubMed Risom T, et al. 2022. Cell. 185:299. PubMed Scur M, et al. 2022. Nat Commun. 13:7272. PubMed Canedo EC, et al. 2021. JCI Insight. 6:. PubMed Elhanani O, et al. 2021. Methods Mol Biol. 2386:147. PubMed |
| Gene ID | NA |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Avidin/Biotin Blocking Kit |
|---|
| Previously | Covance Catalog# SIG-31126 |
|---|